Literature DB >> 9670611

Clinical trials with blocked ricin immunotoxins.

J E O'Toole1, D Esseltine, T J Lynch, J M Lambert, M L Grossbard.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9670611     DOI： 10.1007/978-3-642-72153-3_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  4 in total

Review 1.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

2.  Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.

Authors:  M Tommasi; D Castelletti; M Pasti; G Fracasso; I Lorenzetti; S Sartoris; C Pera; G B Ferrara; G Tridente; M Colombatti
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

3.  A calcium ion-dependent dimeric bean lectin with antiproliferative activity toward human breast cancer MCF-7 cells.

Authors:  Randy Chi Fai Cheung; Ho Him Leung; Wen Liang Pan; Tzi Bun Ng
Journal:  Protein J       Date:  2013-03       Impact factor: 2.371

4.  Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins.

Authors:  Javier Ruiz-de-la-Herrán; Jaime Tomé-Amat; Rodrigo Lázaro-Gorines; José G Gavilanes; Javier Lacadena
Journal:  Toxins (Basel)       Date:  2019-10-12       Impact factor: 4.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.